Long-term PPI use may cause serious hypomagnesemiaU.S. FDA communicating safety concerns regarding potential development of hypomagnesemia when PPIs taken for prolonged periods. Gilenya: new MS drug approved by Health CanadaHealth Canada approves first disease-modifying oral treatment for multiple sclerosis in Canada. Rx subs often OK if no kickback Osteoporosis | Canadian study confirms link between bisphosphonates and fracture risk Is money war on in Alberta? Government wants to kill hard-won AMA programs, services for members Pharmacist immunization off the table in Ontario, for now The Ontario College of Pharmacists has decided not to pursue full immunization authority at this time. PICTURE YOURSELF: Spreading the gospel! LETTER: Online ‘data clouds’ offer a brighter future for EMRs? Cardiology | Drink to your health Peak experience: Climbing a fundraising mountain First Previous 3451 3452 3453 3454 3455 Next Last
